Abbreviated New Drug Applications

Rediff.com » News » Abbreviated New Drug Applications

News for Abbreviated New Drug Applications

Business

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. Gland Pharma's......

US drug shortage a shot in the arm for Indian pharmaceutical companies

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Image used......

Glenmark buys certain OTC drugs from Wockhardt in US

Glenmark Pharmaceuticals Ltd on Tuesday said it has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the US. The acquisition by the company's......

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out......

US to charge fee on generic drug sale application

All generic pharmaceutical companies, including Ranbaxy Laboratories, Cipla, Dr Reddy's Laboratories, Lupin, Glenmark and Torrent Pharma, might soon have to pay a fee to the US drug regulator when......

Rediff News

Abbreviated New Drug Applications

News for Abbreviated New Drug Applications

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

US drug shortage a shot in the arm for Indian pharmaceutical companies

Glenmark buys certain OTC drugs from Wockhardt in US

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

US to charge fee on generic drug sale application

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS